Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0003 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |